Zai Lab LtdZLAB
Market cap
$29.9B
P/E ratio
| Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Product revenue, net | - | 129,452 | 13 | 49 | 144 | 215 | 267 | 399 |
| Collaboration revenue | - | - | - | - | 0 | 2 | - | 1 |
| Cost of product revenue | - | - | - | - | - | - | - | 147 |
| Cost of collaboration revenue | - | - | - | - | - | - | - | 1 |
| Research and development | 39 | 120 | 142 | 223 | 573 | 286 | 266 | 235 |
| Selling, general and administrative | - | 22 | 70 | 111 | 219 | 259 | 282 | 299 |
| Gain on sale of intellectual property | - | - | - | - | - | - | 10 | - |
| Loss from operations | -51,391,036 | -141,768,082 | -203 | -302 | -700 | -404 | -367 | -282 |
| Interest income | 527,351 | 3 | 8 | 5 | 2 | 15 | 40 | 37 |
| Interest expenses | - | 39,672 | 0 | 0 | - | - | - | 2 |
| Foreign currency losses | - | - | - | - | - | -56 | -15 | -15 |
| Other income, net | - | - | 1 | 29 | -6 | 3 | 7 | 5 |
| Loss before income tax and share of loss from equity method investment | -50,134,524 | -138,488,344 | -194 | -268 | -703 | -443 | -335 | -257 |
| Income tax expense | - | - | - | - | - | - | - | - |
| Share of loss from equity method investment | -249,652 | -586,551 | - | -1 | -1 | -0 | - | - |
| Net loss | -50,384,176 | -139,074,895 | -195 | -269 | -704 | -443 | -335 | -257 |
| Earnings Per Share, Basic | - | - | - | - | - | -0.46 | -0.35 | -0.26 |
| Earnings Per Share, Diluted | - | - | - | - | - | -0.46 | -0.35 | -0.26 |